Junwei Li
Qingdao, 266109, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Influenza mRNA vaccine with engineered panhandle-forming UTRs provides potent, dose-sparing protection against seasonal influenza viruses.
Journal: NPJ vaccines
Published: December 25, 2025
A Self-Assembled Nanobody Against the Haemagglutinin of Influenza a Virus Shows Enhanced Stability and Efficacy In Vitro and In Vivo.
Journal: Frontiers in bioscience (Landmark edition)
Published: October 13, 2025
Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer.
Journal: Frontiers in immunology
Published: October 27, 2022
Adjuvant therapy fails to show survival benefit for patients with spindle cell carcinoma: Evidence from the surveillance, epidemiology, and end results database.
Journal: Journal of cancer research and therapeutics
Published: December 01, 2021
Immune-related organizing pneumonitis in non-small cell lung cancer receiving PD-1 inhibitor treatment: A case report and literature review.
Journal: Journal of cancer research and therapeutics
Published: February 10, 2021
TH17 cells…Sorting the good out from the bad.
Journal: Signal transduction and targeted therapy
Published: August 08, 2020
Targeting IL-22 and IL-22R protects against experimental osteoarthritis.
Journal: Cellular & molecular immunology
Published: June 08, 2020
Mapping the T cell response to COVID-19.
Journal: Signal transduction and targeted therapy
Published: May 27, 2020
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Journal: Virologica Sinica
Published: March 20, 2020
Protecting against different subtypes of influenza viruses: a nanoparticle approach.
Journal: Signal transduction and targeted therapy
Published: March 03, 2020
Adiponectin exacerbates influenza infection in elderly individuals via IL-18.
Journal: Signal transduction and targeted therapy
Published: December 30, 2019
Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
Journal: Drug design, development and therapy
Published: May 02, 2019
Last Updated: 09/26/2026